Home Newsfeeds Athira Pharma Q2 EPS $(0.65) Down From $(0.38) YoY

Athira Pharma Q2 EPS $(0.65) Down From $(0.38) YoY

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(0.65) per share. This is a 71.05 percent decrease over losses of $(0.38) per share from the same period last year.

Morgan Stanley Downgrades Affirm Holdings to Equal-Weight, Lowers Price Target to $15

By Benzinga Newsdesk

February 10, 6:53 AM

Morgan Stanley analyst James Faucette downgrades Affirm Holdings (NASDAQ:AFRM) from Overweight to Equal-Weight and lowers the price target from $46 to $15.

AFRM

Vista Outdoor Announces Public Filing Of Form 10 Registration Statement; Targets Q4 Of Calendar Year 2023 For Spin-Off Of Outdoor Products Segment; Provides An Update On The Outdoor Products Company Post-Spin

By Happy Mohamed

September 5, 4:16 PM

Targets fourth quarter of calendar year 2023 for spin-off of Outdoor Products segment Provides an update on the Outdoor Products company post-spin Vista Outdoor Inc. (NYSE:VSTO), the parent company of 41

VSTO

Maximus Awarded $32M IRS Data Delivery Services Task Order

By Benzinga Newsdesk

January 4, 12:03 PM

New Contract Expands Work with IRS to Provide Support for Mission-Critical SystemsMaximus (NYSE:MMS), a leading employer and provider of government services worldwide, today announced it has been awarded a four-year, $32

MMS